7.384-element silicon chip spectrochip (Sequenom)
90
Structured Review
Sequenom
7.384-element silicon chip spectrochip
7.384 Element Silicon Chip Spectrochip, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/silicon+chip+spectrochip/384+element+silicon+chip+spectrochip/us11827928-590-0-5
Average 90 stars, based on 1 article reviews
7.384 Element Silicon Chip Spectrochip, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/silicon+chip+spectrochip/384+element+silicon+chip+spectrochip/us11827928-590-0-5
Average 90 stars, based on 1 article reviews
7.384-element silicon chip spectrochip - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Amplification:Article Title: Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study. Article Snippet: LA Lange*, JM Norris, CD Langefeld, BJ Nicklas, LE Wagenknecht, MF Saad and DW Bowden Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO, USA; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Diabetes Center, University of California, Los Angeles, Alhambra, CA, 91801, USA; and Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, USA Article Title: Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study. Article Snippet: Objective: Plasminogen activator inhibitor type-1 (PAI-1) plays a central role in fibrolysis and has recently been hypothesized to influence components of the insulin resistance syndrome.. We consider whether the 4G/5G polymorphism influences components of insulin resistance and obesity solely through PAI-1 protein levels or also though a secondary pathway.. In addition, we explore whether transforming growth factor (TGF-ß1), a key regulator of PAI-1 expression, modifies the influence of the PAI-1 4G/5G polymorphism on these traits. Purification:Article Title: Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study. Article Snippet: LA Lange*, JM Norris, CD Langefeld, BJ Nicklas, LE Wagenknecht, MF Saad and DW Bowden Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO, USA; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Diabetes Center, University of California, Los Angeles, Alhambra, CA, 91801, USA; and Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, USA Article Title: Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study. Article Snippet: Objective: Plasminogen activator inhibitor type-1 (PAI-1) plays a central role in fibrolysis and has recently been hypothesized to influence components of the insulin resistance syndrome.. We consider whether the 4G/5G polymorphism influences components of insulin resistance and obesity solely through PAI-1 protein levels or also though a secondary pathway.. In addition, we explore whether transforming growth factor (TGF-ß1), a key regulator of PAI-1 expression, modifies the influence of the PAI-1 4G/5G polymorphism on these traits. |